Working within the Center for Neuro-Oncology at Dana-Farber Brigham Cancer Center, our neuro-oncologists are leading basic, translational and clinical research aimed at advancing brain tumor diagnosis and treatment. Our research staff focuses on the following major areas:
In the research laboratory and the clinic, we are also studying:
- CNS and systemic lymphoma
- Brain metastasis
- Adaptive designs for brain tumor clinical trials
- Neurologic complications of cancer
- Oncolytic viruses
- Surgical brain mapping
- Molecular and cellular surgical oncology
- CNS drug delivery/mass spectrometry
- Tumor metabolism/IDH mutations
- Olig 2 suppression
- Advanced neuro-imaging
Clinical Trials
As we search for new, more effective treatments, we are able to offer our patients access to a range of neuro-oncology clinical trials that explore innovative approaches to improve outcomes and quality of life for brain tumor patients, including immunotherapy, targeted therapies, and anti-angiogenesis inhibitors.
Learn more about our neuro-oncology clinical trials:
- Newly diagnosed brain tumors
- Recurrent glioblastoma
- Non-glioblastoma brain tumors
